340 related articles for article (PubMed ID: 16780770)
1. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model.
Gao L; Chen L; Fei XH; Qiu HY; Zhou H; Wang JM
Chin Med J (Engl); 2006 Jun; 119(11):911-8. PubMed ID: 16780770
[TBL] [Abstract][Full Text] [Related]
2. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
Cucco C; Calabretta B
Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
[TBL] [Abstract][Full Text] [Related]
4. In vivo acquired drug resistance and multidrug resistance gene (MDR1) expression in the KB carcinoma cell line xenotransplanted in nude mice.
Abe Y; Nakamura M; Saegusa R; Ueyama Y; Ogata T; Tamaoki N
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):99-106. PubMed ID: 7701536
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma].
Zhu L; Lang J; Shen K
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):462-6. PubMed ID: 9639738
[TBL] [Abstract][Full Text] [Related]
6. Expression of the human multidrug resistance gene mdr1 in leukemic cells and its application in studying P-glycoprotein antagonists.
Fu J; Chen Z; Cen J; Ruan C
Chin Med J (Engl); 2000 Mar; 113(3):228-31. PubMed ID: 11775252
[TBL] [Abstract][Full Text] [Related]
7. 5-Azacytidine modulates the response of sensitive and multidrug-resistant K562 leukemic cells to cytostatic drugs.
Efferth T; Futscher BW; Osieka R
Blood Cells Mol Dis; 2001; 27(3):637-48. PubMed ID: 11482878
[TBL] [Abstract][Full Text] [Related]
8. Advantage of in vivo chemosensitivity assay to detect vincristine-resistance in a human epidermoid carcinoma xenograft.
Abe Y; Yamazaki H; Oshika Y; Suto R; Tsugu A; Ota E; Satoh H; Ohnishi Y; Yanagawa T; Ueyama Y; Tamaoki N; Nakamura M
Anticancer Res; 1996; 16(2):729-34. PubMed ID: 8687121
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms.
Urasaki Y; Ueda T; Yoshida A; Fukushima T; Takeuchi N; Tsuruo T; Nakamura T
Anticancer Res; 1996; 16(2):709-14. PubMed ID: 8687117
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance mediated by overexpression of P-glycoprotein in human osteosarcoma in vivo.
Suto R; Abe Y; Nakamura M; Ohnishi Y; Yoshimura M; Lee YH; Imanishi T; Yamazaki H; Kijima H; Tokunaga T; Oshika Y; Hiraoka N; Tamaoki N; Fukuda H; Ueyama Y
Int J Oncol; 1998 Feb; 12(2):287-91. PubMed ID: 9458350
[TBL] [Abstract][Full Text] [Related]
11. Time dependence of [3H]-vincristine accumulation by L1210 mouse leukemic cells. Effect of P-glycoprotein overexpression.
Breier A; Stefanková Z; Barancík M; Tribulová N
Gen Physiol Biophys; 1994 Aug; 13(4):287-98. PubMed ID: 7890145
[TBL] [Abstract][Full Text] [Related]
12. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
[TBL] [Abstract][Full Text] [Related]
13. A non-P-glycoprotein-mediated mechanism of vincristine transport which is affected by resistance modifiers and present in chemosensitive cells.
Gruber A; Larsson R; Nygren P; Björkholm M; Peterson C
Leukemia; 1994 Jun; 8(6):985-9. PubMed ID: 7911547
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal cross-resistance in human rhabdomyosarcomas selected in vivo for primary resistance to vincristine and L-phenylalanine mustard.
Horton JK; Houghton PJ; Houghton JA
Cancer Res; 1987 Dec; 47(23):6288-93. PubMed ID: 2890432
[TBL] [Abstract][Full Text] [Related]
15. Enhanced potency of daunorubicin against multidrug resistant subline KB-ChR-8-5-11 by a pulsed magnetic field.
Liang Y; Hannan CJ; Chang BK; Schoenlein PV
Anticancer Res; 1997; 17(3C):2083-8. PubMed ID: 9216668
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by erythroid differentiation factor (activin A) of P-glycoprotein expression in multidrug-resistant human K562 erythroleukemia cells.
Okabe-Kado J; Hayashi M; Honma Y; Hozumi M; Tsuruo T
Cancer Res; 1991 May; 51(10):2582-6. PubMed ID: 1673636
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicin.
Yang CZ; Luan FJ; Xiong DS; Liu BR; Xu YF; Gu KS
Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):333-7. PubMed ID: 7668104
[TBL] [Abstract][Full Text] [Related]
18. Effect of pentoxifylline on P-glycoprotein mediated vincristine resistance of L1210 mouse leukemic cell line.
Breier A; Barancík M; Stefanková Z; Uhrík B; Tribulová N
Neoplasma; 1994; 41(5):297-303. PubMed ID: 7854500
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines.
Nakanishi O; Baba M; Saito A; Yamashita T; Sato W; Abe H; Fukazawa N; Suzuki T; Sato S; Naito M; Tsuruo T
Oncol Res; 1997; 9(2):61-9. PubMed ID: 9167187
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of etoposide and vincristine by two synthetic 1,4-dihydropyridine derivatives in multidrug-resistant and atypical multidrug-resistant human cancer cells.
Watanabe Y; Takano H; Kiue A; Kohno K; Kuwano M
Anticancer Drug Des; 1991 Feb; 6(1):47-57. PubMed ID: 2015041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
